Rare disease news, mapped to the diseases behind the headlines. AI-classified across pipeline, policy, funding, science, and community.
Be among the first to receive Kisho Intelligence Briefings
Showing news related to
Showing 1–1 of 1 stories
A new observational study sponsored by the National Cancer Institute aims to evaluate treatment responses in patients with advanced central nervous system tumors, including various types of gliomas. The study is currently not yet recruiting participants.
Get the week's most important rare disease developments — pipeline moves, policy changes, and funding signals — delivered to your inbox every Monday.
Free weekly briefing. Unsubscribe anytime.